Cargando…

Autoimmune Hemolysis: A Journey through Time

The existence of autoimmune diseases in humans has been known for almost 100 years. Currently, autoimmune pathogenesis has been attributed to more than 40 human diseases; yet it is still not clear what immune abnormalities conclusively prove underlying autoimmune pathogenesis. Hence, although much h...

Descripción completa

Detalles Bibliográficos
Autor principal: Freedman, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678316/
https://www.ncbi.nlm.nih.gov/pubmed/26696795
http://dx.doi.org/10.1159/000437195
_version_ 1782405434482622464
author Freedman, John
author_facet Freedman, John
author_sort Freedman, John
collection PubMed
description The existence of autoimmune diseases in humans has been known for almost 100 years. Currently, autoimmune pathogenesis has been attributed to more than 40 human diseases; yet it is still not clear what immune abnormalities conclusively prove underlying autoimmune pathogenesis. Hence, although much has been learned, research is still needed for complete elucidation of the mechanisms of the immune dysregulation in AIHA. Better understanding of the underlying mechanism(s) may allow for development of more specific therapies of these not uncommon and often difficult-to-treat disorders.
format Online
Article
Text
id pubmed-4678316
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-46783162015-12-22 Autoimmune Hemolysis: A Journey through Time Freedman, John Transfus Med Hemother Review Article The existence of autoimmune diseases in humans has been known for almost 100 years. Currently, autoimmune pathogenesis has been attributed to more than 40 human diseases; yet it is still not clear what immune abnormalities conclusively prove underlying autoimmune pathogenesis. Hence, although much has been learned, research is still needed for complete elucidation of the mechanisms of the immune dysregulation in AIHA. Better understanding of the underlying mechanism(s) may allow for development of more specific therapies of these not uncommon and often difficult-to-treat disorders. S. Karger AG 2015-09 2015-08-10 /pmc/articles/PMC4678316/ /pubmed/26696795 http://dx.doi.org/10.1159/000437195 Text en Copyright © 2015 by S. Karger GmbH, Freiburg http://www.karger.com/Authors_Choice This is an open access article distributed under the terms of Karger's Author's Choice™ licensing agreement, adapted from the Creative Commons Attribution Non-Commercial 2.5 license. This license allows authors to re-use their articles for educational and research purposes as long as the author and the journal are fully acknowledged.
spellingShingle Review Article
Freedman, John
Autoimmune Hemolysis: A Journey through Time
title Autoimmune Hemolysis: A Journey through Time
title_full Autoimmune Hemolysis: A Journey through Time
title_fullStr Autoimmune Hemolysis: A Journey through Time
title_full_unstemmed Autoimmune Hemolysis: A Journey through Time
title_short Autoimmune Hemolysis: A Journey through Time
title_sort autoimmune hemolysis: a journey through time
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678316/
https://www.ncbi.nlm.nih.gov/pubmed/26696795
http://dx.doi.org/10.1159/000437195
work_keys_str_mv AT freedmanjohn autoimmunehemolysisajourneythroughtime